Clinical Trials Update: Jan. 18, 2007
Diabetes - Type 1 Generalized Anxiety Disorder (GAD) Weight Loss
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Diabetes - Type 1
This 13-month clinical trial is for people between the ages of 18 and 80 who have type 1 diabetes. The study will evaluate an inhaled insulin product that is not yet approved by the U.S. Food and Drug Administration (FDA). The treatment period is one year (12 visits), with a followup visit in the subsequent month.
The research sites are located across the United States.
Generalized Anxiety Disorder (GAD)
This study will evaluate an investigational medication to treat generalized anxiety disorder. The study is open to people 18 or older who can read and speak English fluently, who do not have certain conditions such as major depressive disorder or obsessive-compulsive disorder, and who have not responded to other medication for GAD.
The research site is in Sherman Oaks, Calif.
This clinical research study will evaluate an investigational medication for weight loss. You may qualify if you are male, 18 to 55 years of age, a non-smoker, and overweight. Compensation for time and travel is available.
The research site is in Philadelphia, Penn.
Copyright 2007 Thomson CenterWatch. All rights reserved.